PRS42 IMPACT OF THE UK PUBLIC SMOKING BAN ON THE PRESCRIBING OF SMOKING CESSATION THERAPY IN PRIMARY CARE^A THIN DATABASE STUDY  by Blak, BT et al.
Abstracts A203
insurance coverage (OR, 1.768; CI,1.745–1.792)and those having higher income 
(OR,1.168;CI,1.155–1.182)were found to have higher odds of using inhaled cortico-
steroids when compared to uninsured and people from low income categories respec-
tively. Aside from these, disease severity also predicted the use of controller drug. 
Patients with increased severity had higher odds of using ICSs (OR, 1.552; CI, 
1.537–1.568). The ﬁndings held true even after adjusting for other demographic 
factors. CONCLUSIONS: Underuse of ICSs continues to be a problem in asthma 
patients. This not only makes the control of disease difﬁcult but shoots up the health-
care expenditure. The study was successful in ﬁnding out vulnerable populations that 
can be targeted for inhaled corticosteroids use. The importance of adherence to treat-
ment and inhaled corticosteroids use are issues that need to be addressed.
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OBJECTIVES: To assess the impact of REMS approval on prescription pattern for 
three oral drugs used to treat common chronic conditions. We assessed relative impact 
on prescription volume for REMS-approved drugs against relevant competitors not 
requiring REMS. We described these trends over the 2006–2009 period including the 
9/27/2007 implementation of the REMS initiative. METHODS: We paired two top 
prescribed drugs for the treatment of asthma (Advair/Singulair), diabetes (Actos/
Avandia) and insomnia (Ambien/Lunesta). Each pairing included a REMS-approved 
drug (Advair, Actos and Ambien). We focused on the months leading to and following 
REMS approvals. For each pairing, volume of total prescriptions (TRx), new prescrip-
tions (NRx) and prescription switches (SRx) were collected using the Verispan’s 
VONA database. Statistical analyses were performed using one-way ANOVA. 
RESULTS: There were no signiﬁcant changes (p < 0.05) in the volume of TRx, NRx 
and SRx for Advair or Actos prior to or following approval. However, Ambien TRx 
were signiﬁcantly higher during and after the last quarter of 2008 compared to previ-
ous months (p = .008) while SRx were lower (p = 0.04). This increase did not come 
to the expense of Lunesta whose prescription volume stayed constant over the time 
period considered. CONCLUSIONS: The fear that additional safety requirements 
could be detrimental to drug prescriptions was not conﬁrmed in our analyses. In fact, 
FDA requirement for REMS approval appeared to impact prescription volume favor-
ably for one of the drugs considered. One possible explanation is the potential for 
increased interactions with providers thus the ability to better position the drug clini-
cally. However, these trends were observed with less than a two-year period post-
approval and only for a handful of drugs and conditions. Additionally, the differential 
impact of various REMS components such as medical guide and communication plan 
should be further investigated.
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OBJECTIVES: To examine recent anti-allergic drug utilization patterns in adult 
patients with allergic rhinitis using National Ambulatory Care Survey data. 
METHODS: Data for this study was obtained from the 2006 and 2007 National 
Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory 
Medical Care Survey (NHAMCS) public use data ﬁles. Visits with a primary diagnosis 
of allergic rhinitis in adults (age >18 years) were identiﬁed. Descriptive weighted 
statistics was used to examine utilization patterns of various anti-allergic medications. 
A multivariate survey logistic was conducted to determine demographic and geo-
graphic variations associated with anti-allergic medication use in patients with allergic 
rhinitis. RESULTS: Allergic rhinitis accounted for 18.6 million adult ambulatory care 
visits in the United States. The majority of the visits were made by females (61.6%), 
whites (84.8%), and involved specialists (59.9%). Anti-allergic medications were 
prescribed in 55.1% (95%CI 39.2% −71.0%) of the total diagnosed visits. Antihis-
tamines were the most commonly prescribed anti-allergic medication (37.4%) (95%CI 
32.4%-46.5%) followed by intranasal steroids (28.3%) (95%CI 23.2%-31.8%). 
Topical nasal antihistamines and decongestants (7.8%) (95%CI 2.7%-9.9%), leukot-
rienes (6.3%) (95%CI 5.2%-6.8%), corticosteroids (3.4%) (95%CI 1.3%-4.3%), and 
oral decongestants (1.52%) (95%CI 0.4%-2.1%) were the least prescribed anti-
allergic medications. The multivariate logistic regression revealed that geographic 
region of the ofﬁce visits was signiﬁcantly associated with medication use. Outpatient 
visits in the Midwest (Odds Ratio (OR) 5.16, 95%CI 1.50–17.67), South (OR 6.3, 
95%CI 2.03–19.5), and West (OR 9.16, 95%CI 2.39–35.11) regions were more likely 
to be prescribed anti-allergic medications compared to those in the Northeast region. 
CONCLUSIONS: Anti-allergic medications were prescribed in over half of adult 
allergic rhinitis visits in the U.S. The ﬁndings highlight geographical variations in 
anti-allergic medication use for allergic rhinitis. Comprehensive research is needed to 
understand the reasons for geographic variation in the medication use for allergic 
rhinitis.
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OBJECTIVES: Over-the-counter nicotine replacement purchases increased immedi-
ately after the public smoking ban introduction in Scotland. The study objective was 
to evaluate the impact of the smoking bans throughout the UK on smoking cessation 
prescriptions (SCPs) or related general practice contacts (GPCs) in primary care. 
METHODS: Monthly data on SCPs (nicotine replacement therapy, bupropion, vareni-
cline) and GPCs were obtained from The Health Improvement Network (THIN) 
database, which holds anonymised longitudinal UK primary care data, 24 months 
before and after the ban in England (January 7, 2007), Wales (February 4, 2007), 
Scotland (March 26, 2006) and Northern Ireland (NI) (April 30, 2007). The percent-
age of active patients with ≥1 SCP and the percentage of GPCs which were smoking 
cessation-related were evaluated. Mann-Whitney tests compared percentages before 
and after the ban. RESULTS: Within each country SCPs increased slightly after the 
smoking ban, for example during the total 48 months 431,675 SCPs were prescribed 
in England, with 48.7% prescribed before the ban and 51.3% after. The median 
percentage of patients with ≥1 SCP increased slightly after the ban—in England the 
median was 0.28% before and 0.31% after, with no evidence of a difference (p = 
0.18), in Wales 0.36% and 0.49% (p = 0.001) respectively, Scotland 0.36% and 
0.37% (p = 0.85), and NI 0.48% and 0.54% (p = 0.09). The median percentage of 
GPCs decreased slightly—in England it was 1.87% before and 1.57% after, Wales 
2.08% and 1.81% respectively, Scotland 2.70% and 1.64%, and NI 2.95% and 
2.34%. There was evidence of a difference (p < 0.0001) in each country. CONCLU-
SIONS: The ban did not seem to impact smoking cessation activity in primary care 
greatly. Even though only signiﬁcant for Wales, the slight increase in patients with 
SCPs may be owing to the ban. The decrease in smoking-related GPCs could be owing 
to patients being referred to or seeking support outside of primary care.
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OBJECTIVES: In the absence of community-based databases on antibiotic use in 
developing countries recently a methodology was established for surveillance of anti-
biotic use at New Delhi by conducting ‘Exit Interviews’ of the patients. This study 
was conducted to obtain information on current prescribing rates of antibiotics in 
acute respiratory illnesses (ARI), a condition where misuse of antibiotics is common. 
METHODS: Antibiotic use data was collected from public and private sector facilities 
from four municipal wards (residential localities) around a tertiary care hospital where 
the antibiotic resistance work was being conducted. For public sector, 8 dispensaries 
(primary health care) and 2 secondary care level facilities were enrolled. For private 
sector, 20 willing and cooperative general practitioners and specialists practising in 
the chosen areas were selected. Patients after consultation with prescriber were asked 
if they had cough/common cold/sore throat (symptoms of ARI). Patients with any of 
these symptoms were enrolled for exit interview and his/her prescription was moni-
tored. Antibiotic use data was collected per month over one year (December 
2007-November 2008).The percentage of patients receiving antibiotic and pattern of 
consumption for various antibiotics was analysed. RESULTS: At public facilities 
45.3% (746/1646) and at private facilities 56.7% (259/457) of patients with ARI were 
prescribed at least one antibiotic. In public sector, macrolides (29.3%), penicillins 
(26.3%), and cephalosporins (16.2%) and in private sector, cephalosporins (40%), 
ﬂuoroquinolones (21.7%), and penicillins (19.7%) were mainly prescribed. At public 
facilities, main members from macrolides were roxithromycin and erythromycin; for 
penicillins, amoxicillin and amoxicillin+clavulinic acid; for cephalosporins, cefuroxime 
and cephalexin were used. At private clinics, for cephalosporins, cefuroxime, cefpo-
doxime proxetil, ceﬁxime, ceﬁxime+clavulinic acid; for ﬂuoroquinolones, levoﬂoxacin 
and oﬂoxacin; and for penicillins group amoxicillin+clavulinic acid were prescribed. 
CONCLUSIONS: Over-prescription and irrational use of antibiotics was seen in ARI. 
In-depth behaviour study for prescribers and strategies to manage ARI are needed.
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OBJECTIVES: Substantial overuse of newer broad-spectrum antibiotics has been a 
grave public health concern as it results in drug resistance and substantial health care 
costs. Little is known about how health insurance status is related with the prescribing 
of antibiotics at the adult primary care. We aim to assess the relationship between 
broad-spectrum antibiotic prescribing and patients’ insurance status in treatment of 
acute respiratory tract infections (ARTI) in adult primary care using a nationally 
representative sample. METHODS: We analyzed 2006 National Ambulatory Medi-
care Care Survey, for adult aged 18 years or older cared for ARTI. Those patients 
with a concomitant diagnosis with other common outpatient infections that might be 
